In 2012, an innovative approach for staged in situ liver transection was proposed that could allow for even more aggressive major hepatectomies. Otherwise, after 25 years, laparoscopy became "traditional" and other minimally invasive techniques continue to be developed but their indications deserve further investigation. Less aggressive treatment in non-complicated diverticulitis becomes more popular, and even antibiotic treatment has been challenged by a randomized study. In colorectal oncology, local resection or observation only seems to become a valuable approach in selected patients with complete response after neo adjuvant chemoradiation. Finally, enhanced recovery pathways (ERAS) have been validated and is increasingly accepted for c...
Colorectal cancer remains one of the most common malignancies worldwide. As liver metastases are fou...
In patients with colorectal liver metastases, hepatic resection is the treatment of choice, and the ...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Multidisciplinary management of colorectal liver metastases allows an increase of about 20% in the r...
2007 was marked by a growing trend towards minimal invasive surgery and enhanced recovery, especiall...
Background: SILS (single incision laparoscopic surgery) and NOTES (natural orifice transluminal endo...
Background. Extensive, bilobular and multifocal colorectal livermetastases (CLM) or metastases that ...
In 2017, data from large multicentre randomized controlled trials assessed the safety of minimally i...
The evolution of visceral surgery is characterized by defining with ever increasing precision the re...
In 2014, surgical management of complex digestive pathology requires a multimodal approach. The asso...
Liver resection remains the method of choice for curative treatment for liver tumors. Development in...
Laparoscopic surgery is now widely used for a variety of indications, including both benign and mali...
Aims: To review the latest strategies and controversies in the surgical treatment of liver metastase...
Colorectal cancer remains the second most common cause of cancer death in the West. Every year in th...
Hepatobiliary surgery has taken a big step forward in recent decades especially in the minimally inv...
Colorectal cancer remains one of the most common malignancies worldwide. As liver metastases are fou...
In patients with colorectal liver metastases, hepatic resection is the treatment of choice, and the ...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...
Multidisciplinary management of colorectal liver metastases allows an increase of about 20% in the r...
2007 was marked by a growing trend towards minimal invasive surgery and enhanced recovery, especiall...
Background: SILS (single incision laparoscopic surgery) and NOTES (natural orifice transluminal endo...
Background. Extensive, bilobular and multifocal colorectal livermetastases (CLM) or metastases that ...
In 2017, data from large multicentre randomized controlled trials assessed the safety of minimally i...
The evolution of visceral surgery is characterized by defining with ever increasing precision the re...
In 2014, surgical management of complex digestive pathology requires a multimodal approach. The asso...
Liver resection remains the method of choice for curative treatment for liver tumors. Development in...
Laparoscopic surgery is now widely used for a variety of indications, including both benign and mali...
Aims: To review the latest strategies and controversies in the surgical treatment of liver metastase...
Colorectal cancer remains the second most common cause of cancer death in the West. Every year in th...
Hepatobiliary surgery has taken a big step forward in recent decades especially in the minimally inv...
Colorectal cancer remains one of the most common malignancies worldwide. As liver metastases are fou...
In patients with colorectal liver metastases, hepatic resection is the treatment of choice, and the ...
Colorectal cancer is the third most common cancer worldwide. Half of CRC patients develop liver meta...